-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Corcept Therapeutics Inc annual/quarterly Depreciation, Depletion and Amortization history and growth rate from 2010 to 2024.
- Corcept Therapeutics Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $68K, a 60.5% decline year-over-year.
- Corcept Therapeutics Inc annual Depreciation, Depletion and Amortization for 2024 was $795K, a 23.7% decline from 2023.
- Corcept Therapeutics Inc annual Depreciation, Depletion and Amortization for 2023 was $1.04M, a 17.2% decline from 2022.
- Corcept Therapeutics Inc annual Depreciation, Depletion and Amortization for 2022 was $1.26M, a 17.4% increase from 2021.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)